BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37496227)

  • 21. Twenty-four-month Progression-free Survival in HER2-amplified Advanced Gastric Cancer with Brain Metastases after Trastuzumab Deruxtecan Treatment: A Case Report and Literature Review.
    Zhang H; Xu M
    Curr Cancer Drug Targets; 2024 Mar; ():. PubMed ID: 38465434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trastuzumab deruxtecan for HER2+ advanced breast cancer.
    Lee J; Park YH
    Future Oncol; 2022 Jan; 18(1):7-19. PubMed ID: 34823373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Two Cases of HER2-Positive Gastric Cancer with Multiple Liver Metastases Leading to Conversion Therapy with Chemotherapy].
    Ono HA; Kaneshiro M; Nakashima M; Baba H; Abe T; Kumagai J; Sugita M
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1662-1664. PubMed ID: 29394735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of unresectable HER2-positive advanced gastric cancer successfully treated by combination therapy with trastuzumab and paclitaxel].
    Ojima E; Nishimura G; Nishijima K; Futagami F; Nakamura T; Hosokawa A
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2339-41. PubMed ID: 23268070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brain Metastasis Arising from Gastric Cancer during Long-Term Treatment Using Nivolumab].
    Namikawa T; Marui A; Yokota K; Kawanishi Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1544-1546. PubMed ID: 36733129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of alpha-fetoprotein-producing gastric cancer with hepatic metastasis successfully treated with combination chemotherapy].
    Kunoki N; Nishiyama R; Ryuzaki H; Oonishi M; Yamamoto T; Uno A; Ogawa M; Ogihara A; Tanaka N; Moriyama M; Sou K; Kinukawa N
    Nihon Shokakibyo Gakkai Zasshi; 2008 Oct; 105(10):1489-95. PubMed ID: 18840987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nivolumab and Gamma Knife Radiosurgery for a Gastric Cancer Patient with Brain Metastasis-A Case Report].
    Yamamoto H; Tanabe S; Ishida Y; Sato H; Takezawa A; Furukawa K; Nakae H; Kobayashi T; Inase M
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):963-965. PubMed ID: 34267037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A Case of HER2-Positive Gastric Cancer with Multiple Liver Metastases Treated with Curative Conversion Therapy after Chemotherapy].
    Kato Y; Natsuki S; Iimori N; Okuno T; Kametani N; Noda E; Yamamoto A; Yamada N; Nishimura S; Taenaka N; Matsunaga Y; Fujita S
    Gan To Kagaku Ryoho; 2020 Apr; 47(4):682-684. PubMed ID: 32389983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case].
    Takahashi T; Kochi M; Kanamori N; Kaiga T; Funada T; Fujii M; Takayama T
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1885-8. PubMed ID: 19920393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A Case of HER2-Positive Unresectable Gastric Cancer with Multiple Lymph Node and Liver Metastases Controlled Effectively by Combination Chemotherapy with Capecitabine, Oxaliplatin, and Trastuzumab].
    Sato N; Nakayama A; Takai Y; Kamata T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1266-1268. PubMed ID: 29394602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
    Shitara K; Bang YJ; Iwasa S; Sugimoto N; Ryu MH; Sakai D; Chung HC; Kawakami H; Yabusaki H; Lee J; Saito K; Kawaguchi Y; Kamio T; Kojima A; Sugihara M; Yamaguchi K;
    N Engl J Med; 2020 Jun; 382(25):2419-2430. PubMed ID: 32469182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
    Kang YK; Chen LT; Ryu MH; Oh DY; Oh SC; Chung HC; Lee KW; Omori T; Shitara K; Sakuramoto S; Chung IJ; Yamaguchi K; Kato K; Sym SJ; Kadowaki S; Tsuji K; Chen JS; Bai LY; Oh SY; Choda Y; Yasui H; Takeuchi K; Hirashima Y; Hagihara S; Boku N
    Lancet Oncol; 2022 Feb; 23(2):234-247. PubMed ID: 35030335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of AFP-producing gastric cancer responding to the combination of systemic chemotherapy, transcatheter arterial embolization and hepatic infusion chemotherapy].
    Shiochi H; Yamada M; Kishina M; Murawaki Y; Miura M; Azumi T; Yuuki T; Tanaka S; Kono M; Yoshimura T; Yoshida M; Shabana M
    Gan To Kagaku Ryoho; 2009 May; 36(5):843-6. PubMed ID: 19461191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of curative surgery for HER2-positive gastric cancer after chemotherapy using paclitaxel combined with trastuzumab].
    Okubo S; Kawabata R; Kimura Y; Kawase T; Ishigaki T; Amano K; Munakata S; Fukunaga M; Ohzato H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2302-4. PubMed ID: 25731503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Remarkable Response to Trastuzumab Observed in a Case of Gastric Cancer with HER2-Negative Conversion].
    Horii N; Morioka D; Yamaguchi K; Sato Y
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1207-1209. PubMed ID: 27760939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New drug approval: Trastuzumab-deruxtecan in HER2 positive advanced gastric or gastroesophageal junction cancer after previous treatment with trastuzumab].
    Duval J; Zaanan A
    Bull Cancer; 2023; 110(7-8):739-740. PubMed ID: 37208251
    [No Abstract]   [Full Text] [Related]  

  • 37. [A Case of Liver Recurrence of Choriocarcinoma and AFP-Producing Carcinoma of the Stomach Showing a Complete Histological Response after Chemotherapy].
    Nakai M; Hara Y; Yonaiyama S; Jin H; Tokura T; Aoki K; Kawashima H; Toyoki Y; Endo M
    Gan To Kagaku Ryoho; 2019 Jan; 46(1):151-153. PubMed ID: 30765671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
    Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
    World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A Case of Advanced Gastric Cancer with Multiple Liver Metastases Successfully Treated with Capecitabine, Cisplatin, and Trastuzumab].
    Oneda Y; Tamura S; Murakami K; Takeno A; Kuwahara R; Akiyama Y; Sakamoto T; Inatome J; Naito A; Katsura Y; Ohmura Y; Kagawa Y; Egawa C; Takeda Y; Kato T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2202-2204. PubMed ID: 28133269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A Patient with HER2-Positive Stage IV Advanced Gastric Cancer Who Received Chemotherapy with Trastuzumab plus XP Followed by Conversion Surgery].
    Yamamoto K; Yamamoto K; Maeda S; Uemura M; Miyake M; Hama N; Nishikawa K; Miyamoto A; Omiya H; Miyazaki M; Ikeda M; Hirao M; Takami K; Nakamori S; Sekimoto M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1942-1944. PubMed ID: 28133183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.